Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrate reductase (NR) is a molybdoenzyme that catalyzes the key two-electron reduction of nitrate (NO3-) to nitrite (NO2-), serving as the first step in nitrate assimilation in plants, algae, fungi, and bacteria, or in dissimilatory processes in prokaryotes.[1][3][4][7] It belongs to the DMSO reductase family and contains a molybdenum cofactor (Mo-MPT or Mo-bisMGD), along with additional prosthetic groups like FAD, heme, and iron-sulfur clusters that facilitate electron transfer from NAD(P)H or quinol donors to the active site.[1][2][3][4] In eukaryotic assimilatory NR, the enzyme is a homodimeric cytosolic protein with distinct domains including Mo-MPT, cytochrome b, and NAD(P)H-binding regions, regulated post-translationally via serine phosphorylation and 14-3-3 protein binding.[1][4] Prokaryotic forms include membrane-bound (Nar) heterotrimers involved in anaerobic respiration and proton motive force generation, and periplasmic (Nap) heterodimers for nitrite production under microaerophilic conditions.[3][4] Crystal structures from organisms like Escherichia coli (NarGHI) and Desulfovibrio desulfuricans (NapA) reveal a conserved Mo coordination sphere with sulfur ligands and oxygen/sulfur terminals, enabling mechanisms involving Mo(IV) to Mo(VI) redox cycles and oxygen atom transfer.[3][4][5] While essential for nitrogen metabolism and crop productivity, NR is not a established therapeutic target in humans, lacking direct roles in mammalian physiology or common disease pathologies.[1][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrate reductase (NR).